EyePoint, Inc.
EYPT
$15.18
-$1.16-7.07%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/6/2025
-
MarketBeat
1/23/2026
-
MarketBeat
1/22/2026
-
MarketBeat
1/16/2026
-
Globe Newswire
1/15/2026
-
MarketBeat
1/12/2026
-
MarketBeat
1/11/2026
-
Simply Wall St
1/10/2026
-
Simply Wall St
1/9/2026
-
MarketBeat
1/8/2026
-
MarketBeat
1/7/2026
-
MarketBeat
1/7/2026
-
TipRanks Financial Blog
1/7/2026
-
Globe Newswire
1/2/2026
-
MarketBeat
12/28/2025
-
MarketBeat
12/26/2025
-
MarketBeat
12/25/2025
-
Simply Wall St
12/23/2025
-
MarketBeat
12/20/2025
-
MarketBeat
12/17/2025
-
Globe Newswire
12/16/2025
-
MarketBeat
12/16/2025
-
Globe Newswire
12/13/2025
-
GuruFocus
12/12/2025
-
Simply Wall St
12/10/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 6, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 926 5000
Address
480 Pleasant Street
Watertown, MA 02472
Watertown, MA 02472
Country
Year Founded
Business Description
Sector
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible...
more